RT characteristics and D-dimer, OS and PFS of patients. by Huriye Senay Kiziltan (22298378)

Subjects:

Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count. by Ana M. Sandoval-Castellanos (11611315)

“…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …”

Results for the asymmetric relationship between military expenditures and DOD energy consumption. by Ryan P. Thombs (9138968)

Subjects:

Coefficient plot of short-run effects. by Ryan P. Thombs (9138968)

Subjects:

Seven forecast scenarios. by Ryan P. Thombs (9138968)

Subjects:

Annual Difference in Energy Consumption Relative to Historical Median Change by 2032. by Ryan P. Thombs (9138968)

Subjects:

Coefficient plot of long-run effects. by Ryan P. Thombs (9138968)

Subjects:

Results for the asymmetric relationship between military expenditures and DOD energy consumption. by Ryan P. Thombs (9138968)

Subjects:

Time series of military expenditures and DOD energy consumption. by Ryan P. Thombs (9138968)

Subjects:

Forecast for each scenario, 2023-2032. by Ryan P. Thombs (9138968)

Subjects:

Summary of study eligibility criteria. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”

Summary of study participation and feasibility. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”

NPF-NPFR pathway in LNd-LPN feedback circuit fine-tune cooling induced locomotion increase. by Xin Yuan (174619)

“…(C, D) Optogenetic activation of LNds using CsChrimson (<i>DvPdf-Gal4>Uas-CsChrimson</i>, red line) decreases sleep and this decrease effect was enhanced by NPF RNAi (<i>DvPdf-Gal4>Uas-CsChrimson; Uas-NPF RNAi</i>; green line). …”

Results obtained from different regression models along with their respective AIC values. by Farzana Afroz (20700794)

Subjects:

Descriptive statistics for the number of under five children death per 100 mothers. by Farzana Afroz (20700794)

Subjects:

Histogram for the number of under five children death per mother. by Farzana Afroz (20700794)

Subjects:

RBM39 methylation by PRMT6 increases RBM39 stability by inhibiting its ubiquitination. by Tongjia Zhang (16496661)

Apoptosis is increased in the ovary of PCOS rats, and there is a correlation between NF-κB-related inflammatory factors, TERT and apoptosis factors. by Haoxuan Xue (19949764)

Contrasting Size Dependence of Photochemical Lifetimes of Polypropylene and Expanded Polystyrene Microplastics in Surface Waters by Ariana Patterson (22764051)

Subjects:

Risk Illustration. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. A 1 kg/m2 increase in BMI is associated with a 6.4% increase in the risk of SCD. …”